Peter Cleavinger, MD
Gastroenterology · Columbia, MONPI 1841244191
Payments from drug & device makers
Across 293 payments — averaging $31.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB Biosciences Inc.$4K
- AbbVie$1K
- Johnson & Johnson$972
- Pfizer$394
- Bristol Myers Squibb$290
- Takeda Pharmaceuticals U.S.A., Inc.$210
- plus $2K from 27 others
What the payments were for
- Food & beverage$5,21997%
- Education$1463%
- Entertainment$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB Biosciences Inc. | 2 | $3,750 |
| AbbVie(2 entities) | 84 | $1,418 |
| Johnson & Johnson(2 entities) | 53 | $972 |
| Pfizer | 28 | $394 |
| Bristol Myers Squibb | 16 | $290 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $210 |
| Amgen | 9 | $201 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $192 |
| Cook Medical LLC | 2 | $190 |
| Lilly USA, LLC | 9 | $186 |
| Sanofi | 5 | $131 |
| Celltrion USA Inc. | 6 | $125 |
| Merck | 7 | $121 |
| Mauna Kea Technologies, Inc. | 5 | $117 |
| Intercept Pharmaceuticals, Inc. | 6 | $95 |
| Janssen Scientific Affairs, LLC | 1 | $94 |
| Phathom Pharmaceuticals, Inc. | 6 | $82 |
| Madrigal Pharmaceuticals | 4 | $66 |
| Organon | 3 | $63 |
| Ipsen Biopharmaceuticals, Inc | 2 | $51 |
| Ferring Pharmaceuticals Inc. | 3 | $50 |
| Ardelyx, Inc. | 3 | $47 |
| Medtronic | 1 | $45 |
| QOL Medical, LLC | 2 | $37 |
| Gilead | 2 | $35 |
| UCB, Inc. | 2 | $30 |
| Novo Nordisk | 1 | $29 |
| Ironwood Pharmaceuticals, Inc | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Fresenius Kabi USA, LLC | 1 | $17 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Shire North American Group Inc | 1 | $15 |
| GSK | 1 | $13 |
How this compares
$9,127 in reported general payments places this provider in the 75th percentile of 374 gastroenterology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 21 | $341,270 |
| RemicadeInfliximab | 33 | $288,511 |
| XifaxanRifaximin | 12 | $39,298 |
| ViberziEluxadoline | 13 | $20,931 |
| Mesalamine ErMesalamine | 12 | $9,343 |
| Dexlansoprazole DrDexlansoprazole | 25 | $6,322 |
| Budesonide EcBudesonide | 26 | $5,313 |
| Budesonide DrBudesonide | 35 | $4,179 |
| Azathioprine | 34 | $2,909 |
| Ursodiol | 18 | $2,602 |
| Omeprazole | 201 | $1,885 |
| CholestyramineCholestyramine (With Sugar) | 13 | $993 |
| Colestipol Hcl | 13 | $752 |
| Pantoprazole Sodium | 42 | $514 |
| Sodium Chloride0.9 % Sodium Chloride | 14 | $39 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonRemicade | $972 | $288,51133 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $192 | $39,29812 claims |
| AbbVieViberzi | $1,418 | $20,93113 claims |
| Fresenius Kabi USA, LLCSodium Chloride | $17 | $3914 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 374 gastroenterology providers in Missouri.
Other gastroenterology in Columbia
- Bradley AndersonColumbia$776K
- Michael WilliamsColumbia$503K
- Yezaz GhouriColumbia$71K
- Jessica StoutColumbia$35K
- Bradley FreilichKansas City$4.5M
- Parakkal DeepakSaint Louis$2M
- Steven FernSullivan$1.4M
- Gregory SayukSaint Louis$1.1M
- Katie SchroederSaint Louis$920K
- Kevin KorenblatSaint Louis$857K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.